Consulting arrangement with the Company at a yearly fee, beginning August 1, 2025
| Officer | Age | In this role | Joined | Source |
|---|---|---|---|---|
|
Christopher Anzalone
Also a director
Chief Executive Officer, President, Director and Board Chair
|
56 | Not stated | Not stated | |
|
Daniel Apel
Chief Financial Officer
|
60 |
Since 2025
1 year
|
2025 | |
|
Patrick O’Brien
Chief Operating Officer
|
62 |
Since 2022
4 years
|
2014 | |
|
James Hamilton
Chief Medical Officer
|
48 |
Since 2025
1 year
|
2014 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Jan 27, 2026 · updated by the 8-K of Jun 16, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Christopher Anzalone
CEO, Board chair
|
56 |
2007
19 years
|
Not stated | None stated | None stated | Paid as CEO | |
|
William Waddill
Lead independent director
|
68 |
2018
8 years
|
Independent |
Audit Committee · Chair
Compensation Committee
Nomination Committee
|
Protagonist Therapeutics, Inc., Annexon, Inc. | $438,184 | |
|
Mauro Ferrari
|
66 |
2010
16 years
|
Independent |
Science Committee · Chair
Audit Committee
Nomination Committee
|
None stated | $420,684 | |
|
Hongbo Lu
|
55 |
2024
2 years
|
Independent |
Science Committee
Nomination Committee
Compensation Committee
|
Terns Pharmaceuticals, Inc., Zenas Biopharma Inc | $420,684 | |
|
Adeoye Olukotun
|
81 |
2020
6 years
|
Independent |
Science Committee · Chair
Nomination Committee
|
Tonix Pharmaceuticals Holding Corp. | $420,684 | |
|
Michael S. Perry
|
66 |
2011
15 years
|
Independent |
Compensation Committee · Chair
Audit Committee
Nomination Committee
Science Committee
|
None stated | $428,184 | |
|
Victoria Vakiener
|
62 |
2022
4 years
|
Independent |
Nomination Committee · Chair
Audit Committee
|
None stated | $424,434 | |
|
Matt Cohen
Joined Jun 12, 2026
|
- | - | - | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Consulting arrangement with the Company at a yearly fee, beginning August 1, 2025
Base salary, bonus and consulting fees earned, plus 100,000 RSUs awarded in fiscal 2025
Employment as Senior Vice President, Investor Relations and Corporate Communications, including base salary, bonus and stock awards
Loading...